Armis Identifies the Riskiest Assets Introducing Threats to Global Businesses
Armis, the leading asset visibility and security company, today released new research identifying the riskiest connected assets posing threats to global businesses. Findings highlight risk being introduced to organizations through a variety of connected assets across device classes, emphasizing a need for a comprehensive security strategy to protect an organization’s entire attack surface in real-time.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905844605/en/
Source: Data from the Armis Asset Intelligence Engine collected between August 2022 and July 2023.
“Continuing to educate global businesses about the evolving and increased risk being introduced to their attack surface through managed and unmanaged assets is a key mission of ours,” said Nadir Izrael, CTO and Co-Founder of Armis. “This intelligence is crucial to helping organizations defend against malicious cyberattacks. Without it, business, security and IT leaders are in the dark, vulnerable to blind spots that bad actors will seek to exploit.”
Armis’ research, analyzed from the Armis Asset Intelligence Engine, focuses on connected assets with the most attack attempts, weaponized Common Vulnerabilities and Exposures (CVEs) and high-risk ratings to determine the riskiest assets.
Assets With The Highest Number of Attack Attempts
Armis found the top 10 asset types with the highest number of attack attempts were distributed across asset types: IT, OT, IoT, IoMT, Internet of Personal Things (IoPT) and Building Management Systems (BMS). This demonstrates that attackers care more about their potential access to assets rather than the type, reinforcing the need for security teams to account for all physical and virtual assets as part of their security strategy.
Top 10 device types with the highest number of attack attempts:
- Engineering workstations (OT)
- Imaging workstations (IoMT)
- Media players (IoT)
- Personal computers (IT)
- Virtual machines (IT)
- Uninterruptible power supply (UPS) devices (BMS)
- Servers (IT)
- Media writers (IoMT)
- Tablets (IoPT)
- Mobile phones (IoPT)
“Malicious actors are intentionally targeting these assets because they are externally accessible, have an expansive and intricate attack surface and known weaponized CVEs,” said Tom Gol, CTO of Research at Armis. “The potential impact of breaching these assets on businesses and their customers is also a critical factor when it comes to why these have the highest number of attack attempts. Engineering workstations can be connected to all controllers in a factory, imaging workstations will collect private patient data from hospitals and UPSs can serve as an access point to critical infrastructure entities, making all of these attractive targets for malicious actors with varying agendas, like deploying ransomware or causing destruction to society in the case of nation-state attacks. IT leaders need to prioritize asset intelligence cybersecurity and apply patches to mitigate this risk.”
Assets With Unpatched, Weaponized CVEs Vulnerable to Exploitation
Researchers identified a significant number of network-connected assets susceptible to unpatched, weaponized CVEs published before 1/1/2022. Zooming in on the highest percentage of devices of each type that had these CVEs between August 2022 and July 2023, Armis identified the list reflected in Figure A. Unpatched, these assets introduce significant risk to businesses.
Assets with a High-Risk Rating
Armis also examined asset types with the most common high-risk factors:
- Many physical devices on the list that take a long time to replace, such as servers and Programmable Logic Controllers (PLCs), run end-of-life (EOL) or end-of-support (EOS) operating systems. EOL assets are nearing the end of functional life but are still in use, while EOS assets are no longer actively supported or patched for vulnerabilities and security issues by the manufacturer.
- Some assets, including personal computers, demonstrated SMBv1 usage. SMBv1 is a legacy, unencrypted and complicated protocol with vulnerabilities that have been targeted in the infamous Wannacry and NotPetya attacks. Security experts have advised organizations to stop using it completely. Armis found that 74% of organizations today still have at least one asset in their network vulnerable to EternalBlue – an SMBv1 vulnerability.
- Many assets identified in the list exhibited high vulnerability scores, have had threats detected, have been flagged for unencrypted traffic or still have the CDPwn vulnerabilities impacting network infrastructure and VoIPs.
- Half (50%) of pneumatic tube systems were found to have an unsafe software update mechanism.
Additional research from Armis is available on the riskiest OT and ICS devices across critical infrastructure industries as well as the riskiest medical and IoT devices in clinical environments.
Learn more about Armis at www.armis.com.
About Armis
Armis, the leading asset visibility and security company, provides the industry’s first unified asset intelligence platform designed to address the new extended attack surface that connected assets create. Fortune 100 companies trust our real-time and continuous protection to see with full context all managed, unmanaged assets across IT, cloud, IoT devices, medical devices (IoMT), operational technology (OT), industrial control systems (ICS), and 5G. Armis provides passive cyber asset management, risk management, and automated enforcement. Armis is a privately held company and headquartered in California.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230905844605/en/
Contact information
Rebecca Cradick
Senior Director, Global Communications
Armis
pr@armis.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 16:00:00 EET | Press release
Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 100 points. TIME and Statista analyzed 3,000 major companies from 150 countries, focusing exclusively on those with trans
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 09:00:00 EET | Press release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 09:00:00 EET | Press release
ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors (corner cube prisms) designed to reflect laser beams directly back to their source, regardless of the an
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 09:00:00 EET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 23:05:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom